Positive influence of being overweight/obese on long term survival in patients hospitalised due to acute heart failure

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Littnerova, Simona ^a   Parenica, Jiri ^a,b,c   Spinar, Jindrich ^a,b,c   Vitovec, Jirí ^a,c   Linhart, Ales ^d   Widimsky, Petr ^e   Jarkovsky, Jiri ^a   Miklik, Roman ^b,c   Spinarova, Lenka ^a,c   Zeman, Kamil ^f   Belohlavek, Jan ^d   Malek, Filip ^g   Felsoci, Marian ^b,c   Kettner, Jiri ^h   Ostadal, Petr ^g   Cihalik, Cestmir ⁱ   Spac, Jiri ^a,c   Al Hiti, Hikmet ^h   Fedorco, Marian ⁱ   Fojt, Richard ^e   Kruger, Andreas ^g   Malek, Josef ^j   Mikusová, Tereza ^c   Monhart, Zdenek ^k   Bohacova, Stanislava ^l   Pohludkova, Lidka ^f   Rohac, Filip ^e   Vaclavik, Jan ⁱ   Vondrakova, Dagmar ^g   Vyskocilova, Klaudia ^c   Bambuch, Miroslav ^l   Dusek, Ladislav ^a   more..

^a MASARYK UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^c ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^d CHARLES UNIVERSITY   (Czech Republic)

^e CHARLES UNIVERSITY   (Czech Republic)

^f Hospital Frydek Mistek   (Czech Republic)

^g NA HOMOLCE HOSPITAL   (Czech Republic)

^h INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

ⁱ UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

^j Hospital Havlickuv Brod   (Czech Republic)

^k Hospital Znojmo   (Czech Republic)

^l Krajska Nemocnice T Bati as   (Czech Republic)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ACUTE HEART FAILURE; AGED; ARTICLE; BODY MASS; BODY WEIGHT; CAUSE OF DEATH; CONTROLLED STUDY; CZECH REPUBLIC; DISEASE ASSOCIATION; FEMALE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBESITY; PROPENSITY SCORE; PROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; ACUTE DISEASE; COHORT ANALYSIS; COMPLICATION; FACTUAL DATABASE; FOLLOW UP; HEART FAILURE; HOSPITALIZATION; MIDDLE AGED; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; SURVIVAL;

ACUTE DISEASE; AGED; BODY MASS INDEX; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS;

EID: 84923372902     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0117142     Document Type: Article

References (30)

1. Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L et al. (2010) Body-mass index and mortality among 1.46 million white adults. N Engl J Med 363: 2211-19. doi: 10.1056/NEJMoa1000367 PMID: 21121834
2. Zheng W, McLerran DF, Rolland B, Zhang X, Inoue M et al. (2011) Association between Body-Mass Index and Risk of Death in More Than 1 Million Asians. N Engl J Med 364: 719-29. doi: 10.1056/NEJMoa1010679 PMID: 21345101
3. Prospective Studies Collaboration (2009) Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 373: 1083-96. doi: 10.1016/S0140-6736(09)60318-4 PMID: 19299006
4. He J, Ogden LG, Bazzano LA, Vupputuri S, Loria C et al. (2001) Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med 161: 996-1002. PMID: 11295963
5. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ et al. (2002) Obesity and the risk of heart failure. N Engl J Med 347: 305-13. PMID: 12151467
6. Wilhelmsen L, Rosengren A, Eriksson H, Lappas G (2001) Heart failure in the general population of men - morbidity, risk factors and prognosis. J Intern Med 249: 253-61. PMID: 11285045
7. Fonarow GC, Srikanthan P, Costanzo MR, Cintron GB, Lopatin M (2007) An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. Am Heart J 153: 74-81. PMID: 17394906
8. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS et al. (2006) Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 113: 898-918. PMID: 16380542
9. Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS et al. (2005) The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med 165: 55-61. PMID: 15642875
10. Diercks DB, Roe MT, Mulgund J, Pollack CV Jr, Kirk JD et al. (2006) The obesity paradox in non-ST-segment elevation acute coronary syndromes: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association Guidelines Quality Improvement Initiative. Am Heart J 152: 140-8. PMID: 16824844
11. Angerås O, Albertsson P, Karason K, Ramunddal T, Matejka G et al. (2013) Evidence for obesity paradox in patients with acute coronary syndromes: a report from the Swedish Coronary Angiography and Angioplasty Registry. Eur Heart J 34: 345-53. doi: 10.1093/eurheartj/ehs217 PMID: 22947610
12. Frankenstein L, Zugck C, Nelles M, Schellberg D, Katus HA et al. (2009) The obesity paradox in stable chronic heart failure does not persist after matching for indicators of disease severity and confounders. Eur J Heart Fail 11: 1189-94. doi: 10.1093/eurjhf/hfp150 PMID: 19887494
13. Perk J, Backer GD, Gohlke H, Graham I, Reiner Z et al. (2012) European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 33: 1653-701.
14. Spinar J, Parenica J, Vitovec J, Widimsky P, Linhart A et al. (2011) Baseline characteristics and hospital mortality in the Acute Heart Failure Database (AHEAD) Main registry. Crit Care 15: R291. doi: 10.1186/cc10584 PMID: 22152228
15. Parenica J, Spinar J, Vitovec J, Widimsky P, Linhart A et al. (2013) Long-term survival following acute heart failure: the Acute Heart Failure Database Main registry (AHEAD Main). Eur J Intern Med 24: 151-60. doi: 10.1016/j.ejim.2012.11.005 PMID: 23219321
16. Nieminen MS, Böhm M, Cowie MR, Dexler H, Filippators GS et al. (2005) Executive summary of the guidelines on the diagnosis and treatment of acute heart failure The Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 26: 384-416. PMID: 15681577
17. Shah R, Gayat E, Januzzi JL, Sato N, Cohen-Solal A et al. (2014) Body mass index and mortality in acutely decompensated heart failure across the world: a global obesity paradox. J Am Coll Cardiol 63: 778-85. doi: 10.1016/j.jacc.2013.09.072 PMID: 24315906
18. Melenovsky V, Kotrc M, Borlaug BA, Marke T, Kovar J et al. (2013) Relationships between right ventricular function, body composition, and prognosis in advanced heart failure. J Am Coll Cardiol 62: 1660-70. doi: 10.1016/j.jacc.2013.06.046 PMID: 23916933
19. Anker SD, Ponikowski P, Varney S, Chua TP, Clark AL et al. (1997) Wasting as independent risk factor for mortality in chronic heart failure. Lancet 349: 1050-3. PMID: 9107242
20. Wu AH, Pitt B, Anker SD, Vincent J, Mujib M et al. (2010) Association of obesity and survival in systolic heart failure after acute myocardial infarction: potential confounding by age. Eur J Heart Fail 12: 566-73. doi: 10.1093/eurjhf/hfq043 PMID: 20354030
21. Evans WJ, Morley JE, Argilés J, Bales C, Baracos V et al. (2008) Cachexia: a new definition. Clin Nutr Edinb Scotl 27: 793-9.
22. Musaad S, Haynes EN (2007) Biomarkers of obesity and subsequent cardiovascular events. Epidemiol Rev 29: 98-114. PMID: 17494057
23. Gao J, Chang Chua C, Chen Z, Wang H, Xu X et al. (2007) Resistin, an adipocytokine, offers protection against acute myocardial infarction. J Mol Cell Cardiol 43: 601-9. PMID: 17904155
24. Tao L, Gao E, Jiao X, Yuan Y, Li S et al. (2007) Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress. Circulation 115: 1408-16. PMID: 17339545
25. Lim SY, Davidson SM, Paramanathan AJ, Smith CCT, Yellon DM et al. (2008) The novel adipocytokine visfatin exerts direct cardioprotective effects. J Cell Mol Med 12: 1395-403. doi: 10.1111/j.1582-4934.2008.00332.x PMID: 18400051
26. Corkins MR, Guenter P, Dimaria-Ghalili RA, Jensen GL, Malone A et al. (2013) Malnutrition Diagnoses in Hospitalized Patients: United States, 2010. J Parenter Enteral Nutr 38: 186-95
27. Iwanaga Y, Kihara Y, Niizuma S, Noguchi T, Nonogi H et al. (2007) BNP in overweight and obese patients with heart failure: an analysis based on the BNP-LV diastolic wall stress relationship. J Card Fail 13: 663-7. PMID: 17923359
28. Horwich TB, Hamilton MA, Fonarow GC (2006) B-type natriuretic peptide levels in obese patients with advanced heart failure. J Am Coll Cardiol 47: 85-90. PMID: 16386669
29. Biondi-Zoccai G, Romagnoli E, Agostoni P, Capodanno D, Castagno D et al. (2011) Are propensity scores really superior to standard multivariable analysis? Contemp Clin Trials 32: 731-40. doi: 10.1016/j.cct.2011.05.006 PMID: 21616172
30. Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S et al. (2010) Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care 33: 920-2. doi: 10.2337/dc09-1825 PMID: 20067971